On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

MANBA

mannosidase beta

The MANBA gene provides instructions for the beta-mannosidase enzyme, crucial for breaking down specific sugar molecules within cellular lysosomes and preventing their accumulation. The MANBA gene encodes the beta-mannosidase enzyme, which plays a vital role in the body's cellular recycling process.

Chromosome 4q24 Various HGNC:6831 Tier C
MANBA 4q24 p arm q arm 4

MANBA is located on the long (q) arm of chromosome 4, at band 4q24. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 4 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The MANBA gene, also known as mannosidase beta, is fundamental for producing the beta-mannosidase enzyme. This enzyme is essential for the proper functioning of lysosomes, which are cellular compartments responsible for waste digestion and recycling. Mutations in MANBA can disrupt this process, leading to the accumulation of specific sugar molecules within cells.

Disruptions to MANBA gene function are primarily associated with beta-mannosidosis, a rare inherited disorder. Understanding the MANBA gene is important for diagnosing and researching conditions linked to impaired cellular metabolism.

What the gene does

The MANBA gene directs the synthesis of beta-mannosidase, an enzyme that operates within lysosomes, the cell's main recycling centres. Its primary role involves the breakdown of sugar molecules, specifically oligosaccharides that are attached to glycoproteins. Beta-mannosidase performs the final step in this catabolic pathway, specifically cleaving disaccharides that contain mannose.

Without a functional beta-mannosidase enzyme, these sugar complexes cannot be properly degraded. This leads to their accumulation within lysosomes, disrupting normal cellular processes and contributing to the symptoms observed in associated conditions. The enzyme's activity is therefore critical for maintaining cellular homeostasis and preventing the build-up of metabolic waste products.

Video: Genetics 101

Chromosome location

The MANBA gene is situated on chromosome 4, specifically at position 4q24. This genomic location specifies where the gene can be found within the human genome. The precise placement of MANBA helps in understanding its genetic context and how it might be inherited.

Protein structure

Domain architecture has not been experimentally characterised in detail for this protein.

Key variants

Variants within the MANBA gene can affect the structure and function of the beta-mannosidase enzyme. These genetic changes can range from small alterations in the DNA sequence to larger structural rearrangements. Pathogenic variants typically lead to a non-functional or reduced-function enzyme, impairing its ability to break down specific sugar molecules.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for MANBA.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1398G>A
single nucleotide variant
p.Trp466Ter Pathogenic ★★☆☆ Beta-D-mannosidosis
c.1434del
Deletion
p.Lys479fs Pathogenic/Likely pathogenic ★★☆☆ Beta-D-mannosidosis
c.1623G>A
single nucleotide variant
p.Trp541Ter Pathogenic/Likely pathogenic ★★☆☆ Beta-D-mannosidosis
c.1648C>T
single nucleotide variant
p.Arg550Ter Pathogenic/Likely pathogenic ★★☆☆ Beta-D-mannosidosis
c.1733del
Deletion
p.Asn578fs Pathogenic ★★☆☆ Beta-D-mannosidosis
c.1753C>T
single nucleotide variant
p.Arg585Ter Pathogenic/Likely pathogenic ★★☆☆ Beta-D-mannosidosis
c.2175dup
Duplication
p.Ser726fs Pathogenic/Likely pathogenic ★★☆☆ Beta-D-mannosidosis
c.544C>T
single nucleotide variant
p.Arg182Trp Pathogenic/Likely pathogenic ★★☆☆ Beta-D-mannosidosis
c.692G>A
single nucleotide variant
p.Trp231Ter Pathogenic/Likely pathogenic ★★☆☆ Beta-D-mannosidosis
c.916del
Deletion
p.Leu306fs Pathogenic/Likely pathogenic ★★☆☆ Beta-D-mannosidosis

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Variants in the MANBA gene are directly linked to beta-mannosidosis, a rare inherited disorder. This condition results from the impaired activity of the beta-mannosidase enzyme, leading to the accumulation of sugar molecules within cells. Beta-mannosidosis primarily affects the nervous system, with a range of symptoms that can vary in severity.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

UK clinical status

The MANBA gene is included in several UK NHS national genomic testing panels. These include panels for intellectual disability, likely inborn errors of metabolism (R98), lysosomal storage disorders (R276), and undiagnosed metabolic disorders. Its inclusion on these panels indicates its recognised clinical significance within the NHS Genomic Medicine Service.

Frequently asked questions

What is the primary function of the MANBA gene?

The MANBA gene provides instructions for making the beta-mannosidase enzyme, which is responsible for breaking down specific complex sugar molecules (oligosaccharides) within the lysosomes, the cell's recycling centres.

What condition is associated with MANBA gene variants?

Variants in the MANBA gene are known to cause beta-mannosidosis. This is an inherited disorder characterised by the accumulation of sugar molecules due to a dysfunctional beta-mannosidase enzyme, primarily affecting the nervous system.

Is the MANBA gene tested in the UK?

Yes, the MANBA gene is part of several NHS national genomic testing panels in the UK, including those for intellectual disability, inborn errors of metabolism, lysosomal storage disorders, and undiagnosed metabolic disorders.

References

  1. Molho-Pessach V, Bargal R, Abramowitz Y. Angiokeratoma corporis diffusum in human beta-mannosidosis: Report of a new case and a novel mutation. Journal of the American Academy of Dermatology. 2007. PMID: 17420068
  2. Zhu M, Lovell KL, Patterson JS. Beta-mannosidosis mice: a model for the human lysosomal storage disease. Human molecular genetics. 2006. PMID: 16377659
  3. Gort L, Duque J, Fabeiro JM. Molecular analysis in two beta-mannosidosis patients: description of a new adult case. Molecular genetics and metabolism. 2006. PMID: 16904924
  4. Uchino Y, Fukushige T, Yotsumoto S. Morphological and biochemical studies of human beta-mannosidosis: identification of a novel beta-mannosidase gene mutation. The British journal of dermatology. 2003. PMID: 12890191
  5. Bedilu R, Nummy KA, Cooper A. Variable clinical presentation of lysosomal beta-mannosidosis in patients with null mutations. Molecular genetics and metabolism. 2002. PMID: 12468273
  6. Alkhayat AH, Kraemer SA, Leipprandt JR. Human beta-mannosidase cDNA characterization and first identification of a mutation associated with human beta-mannosidosis. Human molecular genetics. 1998. PMID: 9384606
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .